Abbreviations

AmDH amine dehydrogenase (variant)
Bb-PhAmDH amine dehydrogenase variant originated from the phenylalanine dehydrogenase from Bacillus badius.
Rs-PhAmDH amine dehydrogenase variant originated from the phenylalanine dehydrogenase from Rhodoccoccus species.
Ch1-AmDH chimeric amine dehydrogenase generated through domain shuffling of BbPhAmDH variant and L-AmDH variant, the latter originated from the leucine dehydrogenase from Bacillus stearothermophilus.
YcnD NADPH oxidase from Bacillus subtilis
Cb-FDH formate dehydrogenase from Candida boidinii
TeS-ADH wild-type alcohol dehydrogenase from Thermoanaerobacter ethanolicus (also known as ADH-T) 
List of substrates
Figure S1
. Secondary alcohols tested in this study. 
General information
Ketones 2a, b, e-i, l-p were purchased from Sigma-Aldrich (Steinheim, Germany). Ketones 2c, d, j, k, were purchased from Alfa Aesar (Shore Road, Heysham, UK).
Aldehydes 2q-t were purchased from Sigma-Aldrich (Steinheim, Germany).
Racemic secondary alcohols 1a, f, i-p primary alcohols 1q-t were purchased from Sigma-Aldrich (Steinheim, Germany). Racemic secondary alcohols 1b-e, g, h were chemically synthesised by reduction with LiAlH 4 from the related ketones. Enantiopure secondary alcohols (S)-1a, i, l-o and enantiopure secondary alcohols (R)-1a, i, were purchased from Sigma-Aldrich (Steinheim, Germany). Enantiopure secondary alcohols (S)-1b-h, j, k, p and (R) 1b-h, j-p were synthesised by enzymatic reduction of the related ketones with stereocomplementary ADHs according to procedures reported in literature. 1 Enantiopure (R), (S) or racemic amines 3f, i, o, p, and non-chiral amines 3q-t were purchased from SigmaAldrich (Steinheim, Germany). Enantiopure (S) and (R) amines 3a-e, g, h, j-n were synthesised by stereoselective amination using established enzymatic methods (commercially available stereocomplementary ω-transaminases). 2 Nicotinamide cofactors (NADH and NAD + ) were purchased from Melford Biolaboratories (Chelsworth, Ipswich, UK).
Catalase from bovine liver was purchased by Sigma-Aldrich (lyophilized powder, >10000 U mg -1 of protein). Catalase (50 U) was added to the reactions from a stock solution previously prepared in aqueous buffer (5 µL of stock solution 1 mg mL -1 ). The concentration of the catalase in the reaction mixture (ca. 0.2 µM) was calculated considering the MM of the monomer (60 kDa) since each monomer contains a catalytic iron site.
Ni 2+ affinity columns (HisTrap FF, 5 mL) and Strep-tag columns (StrepTrap HP, 5 mL) were purchased from GE Healthcare Bio-Sciences (Munich, Germany).
Biotinylated thrombin was purchased from Merck.
Site directed Mutagenesis
The three TeS-ADH variants were obtained by site directed mutagenesis using the QuickChange II SiteDirected Mutagenesis Kit (Agilent Technologies) according to the protocol of the supplier and by using following template DNA (already subcloned into pET21a):
Following primers have been used:
For the double variant, both primer pairs were added to the PCR reaction mixture.
After verifying positive clones by sequencing, E. coli C43 cells were transformed with the DNA and used as host for expression of the proteins.
Expression and purification of recombinant proteins in E. coli host cells
Strep-II-tagged ADH variants from Thermoanaerobacter ethanolicus (Strep TeS-ADH W110A and
I86A W110A)
The C-terminal Strep-II-tagged TeS-ADH variants W110A and I86A W110A -subcloned in pET21a -were expressed in E. coli C43 cells. Cells were grown at 37 °C until an OD 600 of ca. 0.7 was reached prior to the addition of IPTG (final concentration 0.5 mM) and expression was carried out at 20 °C over night. Cultures were harvested, centrifuged and the pellet was washed with an aqueous solution of NaCl (0.9% w w -1 
NADP oxidase (YcnD) from Bacillus subtilis and Formate dehydrogenase from Candida boidinii (Cb-FDH)
BL21 DE3 cells containing the plasmid for the expression of YcnD and Cb-FDH (pET21a, no Tag) were grown at 37 °C until an OD 600 of 0.6 to 0.8 was reached. The expression of the protein was initiated by the addition of IPTG (final concentration 0.5 mM) and carried out at 25 °C overnight. Cells were harvested by centrifugation and washed with an aqueous solution of NaCl (0.9% w w -1 ).
The non-tagged proteins were purified by anion exchange chromatography using a HiPrepQ HP 16/10 column (GE Healthcare). The pellets were dissolved in start buffer (20 mM Tris/HCl, pH 8.0 buffer), a tiny spatula of FMN was added to the YcnD protein solution and after cell disruption and centrifugation the lysates were loaded onto the column and washed with start buffer until the absorbance went down to zero. The elution of the proteins was performed with a gradient between start buffer and elution buffer (20 mM Tris/HCl, 1M NaCl, pH 8.0 buffer).
After SDS-PAGE, fractions containing the desired protein in a sufficient purity were pooled and dialyzed against 50 mM phosphate buffer (pH 8.0) overnight, and concentrated using Centripreps (Millipore). The final concentration was determined spectrophotometrically at 280 nm for Cb-FDH (ɛ 280 = 51,400 M -1 cm -1 , MW = 40.3 kDa) or for YcnD using the wavelength/extinction coefficient for the protein bound flavin (approx. 450 nm/12,190 M -1 cm -1 , MW = 28.9 kDa) as determined by Morokutti et al. 3 Approximately 4 mg and 34 mg pure protein per g wet cells were obtained for YcnD and Cb-FDH, respectively, which were frozen in liquid nitrogen and stored at -80 °C. 
Amine dehydrogenases
The amine dehydrogenases Bb-PhAmDH and Ch1-AmDH were expressed and purified as His 6 -tagged recombinant enzymes as described previously. 4 When required, the His 6 -tag was cleaved following the previous protocol. 4 Rs-PhAmDH was expressed and purified as His 6 -tagged recombinant enzyme as described previously. 5 When required, the His 6 -tag was cleaved as follows.
A solution of His 6 -tagged Rs-PhAmDH (70 mg of enzyme in ca. 1.4 mL of potassium phosphate buffer pH 8.0, 50 mM) was added to the cleavage buffer (20 mL, 20 mM Tris-HCl pH 8.4, 150 mM NaCl, 2.5 mM CaCl 2 ). A solution of biotinylated thrombin was then added (2.8 U). The mixture was incubated at 20 °C for 2 h. Partial precipitation was observed. SDS electrophoresis showed that the cleavage of the His 6 -tag was not complete. Thus, a second aliquot of biotinylated thrombin was added (2.8 U) and incubation was prolonged for other 2 h.
The residual thrombin present in the solution was removed by the addition of streptavidin agarose beads (192 µL of 50% slurry). The beads were then removed by initial centrifugation (4,000 rpm, 10 min, 4 °C) and subsequent further filtration of the supernatant. The final solution contained a mixture of His 6 -tagged Rs-AmDH, Rs-AmDH devoid of His 6 -tag and free His 6 -tag. The fraction of His 6 -tagged Rs-AmDH and the free His 6 -tag were removed through Ni 2+ affinity chromatography. The final solution of highly pure RsAmDH devoid of the His-tag was dialyzed overnight in phosphate buffer (pH 8.0, 50 mM), concentrated, frozen in liquid nitrogen and stored at -80 °C. The enzyme concentration was measured spectrophotometrically (ɛ 280 = 26,500 M -1 cm -1 , MW = 36.7 kDa). The amount of recovered Rs-AmDH devoid of His 6 -tag was 29 mg.
Calculation of the Δ r G'° for (A) biocatalytic hydrogen-borrowing amination (i.e. redoxinterconnected steps) (B) orthogonal biocatalytic network (i.e. concurrent redox separated steps)
Δ r G° is the change in Gibbs free energy due to a chemical reaction in standard conditions (T 298.15 K, P 1 bar) and without accounting for pH and ionic strength. Δ r G'° represents the change in Gibbs free energy due to a chemical reaction in standard conditions considering a particular pH and ionic strength. In this, case we set pH 8.5 and ionic strength 1 M in water as solvent. We chose these conditions as they are analogous to the experimental conditions applied for cascade A (previous work) 4 and cascade B (the present work).
The calculations were performed with the aid of eQuilibrator, a tool made available by Milo Lab at the Weizmann Institute in Rehovot, Israel. 6 eQuilibrator uses a well-studied approximation of Δ f G (the ΔG related to the formation of a given molecule from its components) called group contribution, enabling thermodynamic analysis of many biochemical reactions and pathways. 7 eQuilibrator also allows for manipulation of the conditions of a reaction -pH, ionic strength, and reactant and product concentrations -to help exploring the thermodynamic landscape of a biochemical reaction. Currently, eQuilibrator can provide estimates for many compounds in the KEGG database (about 4500). 8 For simplicity, the calculations were performed using 2-propanol, acetone and 2-propylamine for a representative amination of a secondary alcohol. 1-Butanol, butanal and 1-butylamine were considered in the calculation of a representative amination of primary alcohols.
The calculations of the Δ r G'° values are reported in the tables below
The equilibrium constant for the overall reactions was also calculated as follows: Scheme S1 Biocatalytic hydrogen-borrowing amination (i.e. redox-interconnected steps) for the one-pot conversion of alcohols to enantiopure amines employing alcohol dehydrogenases (ADHs) and amine dehydrogenases (AmDHs); previous work. Cascade B Scheme S2. Orthogonal biocatalytic network (i.e. concurrent redox separated steps) for the one-pot conversion of alcohols to enantiopure amines employing alcohol dehydrogenases (ADHs) and amine dehydrogenases (AmDHs). E. coli/TeS-ADH W110A or E. coli/TeS-ADH I86A (20 mg) were resuspended in Tris-HCl buffer (1 mL, pH 7, 50 mM) containing NADP + (1 mM). The suspension was incubated for 20 min, at 30 °C with orbital agitation (150 rpm). Then, the ketone substrate (50 mM) and isopropanol (50 µl, equal to 5% v v -1 ) were added. The reactions were run for 16 h at 30°C and orbital agitation (150 rpm). The reaction mixtures were extracted with EtOAc (2 x 500 µL) and conversions were measured by GC-FID. The enantiomeric excess of the alcohol was analyzed by GC on a chiral phase after derivatization. Derivatization was performed by adding 4-(N,N-dimethylamino)pyridine (5 mg) dissolved in acetic anhydride (100 µL). After washing with water and drying (MgSO 4 ) the ee value of the derivatized compound was measured. For details on analytical methods and retention times, refer to section "Analytics". 9. Initial studies on the orthogonal biocatalytic network for the asymmetric amination of alcohols Table S13 . Initial studies on the orthogonal biocatalytic network for the amination of (S)-1b (20 mM). Different variants possessing His 6 -tags and devoid of His 6 -tags (YcnD and Ch1-AmDH) were applied at varied concentrations. The other enzymes were Strep-tagged TeS-ADH W110A (varied concentration), Cb-FDH (20 μM), catalase (0.2 µM), NAD + (0.5 mM) and NADP + (0.5 mM). The reaction was carried out in HCOONH 4 buffer (1 M, pH 8.5) at 30 °C with orbital agitation (170 rpm). Table S14 . Time study for the amination of (S)-1b (20 mM) with inversion of configuration. Figure 2 in main paper. 
Studies on the first oxidative cycle of the orthogonal biocatalytic network for the amination of alcohols
Time study for the amination of (S)-1b with inversion of configuration
Sequence alignment between TeS-ADH and Tb-ADH
Sequence alignment between the ADH from Thermoanaerobacter ethanolicus (TeS-ADH) and the ADH from Thermoanaerobacter brockii (Tb-ADH) ************************************************************ TeS-ADH ( 1) MKGFAMLSIGKVGWIEKEKPAPGPFDAIVRPLAVAPCTSDIHTVFEGAIGERHNMILGHE Tb-ADH ( 1) MKGFAMLSIGKVGWIEKEKPAPGPFDAIVRPLAVAPCTSDIHTVFEGAIGERHNMILGHE ****************************** ***************************** TeS-ADH ( 61) AVGEVVEVGSEVKDFKPGDRVVVPAITPDWWTSEVQRGYHQHSGGMLAGWKFSNVKDGVF Tb-ADH ( 61) AVGEVVEVGSEVKDFKPGDRVVVPAITPDWRTSEVQRGYHQHSGGMLAGWKFSNVKDGVF ************************************************************ TeS-ADH ( 121) GEFFHVNDADMNLAHLPKEIPLEAAVMIPDMMTTGFHGAELADIELGATVAVLGIGPVGL Tb-ADH ( 121) GEFFHVNDADMNLAHLPKEIPLEAAVMIPDMMTTGFHGAELADIELGATVAVLGIGPVGL ************************************************************ TeS-ADH ( 181) MAVAGAKLRGAGRIIAVGSRPVCVDAAKYYGATDIVNYKDGPIESQIMNLTEGKGVDAAI Tb-ADH ( 181) MAVAGAKLRGAGRIIAVGSRPVCVDAAKYYGATDIVNYKDGPIESQIMNLTEGKGVDAAI ************************************************************ TeS-ADH ( 241) IAGGNADIMATAVKIVKPGGTIANVNYFGEGEVLPVPRLEWGCGMAHKTIKGGLCPGGRL Tb-ADH ( 241) IAGGNADIMATAVKIVKPGGTIANVNYFGEGEVLPVPRLEWGCGMAHKTIKGGLCPGGRL ************ ***********.************************** 
